Gudmundur Einarsson

Gudmundur Einarsson

Auto-generated profile, based on publicly available information

Gudmundur Einarsson

DeCODE genetics/AMGEN Inc., Reykjavik, Iceland

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 October 2023 in Nature Genetics
Verified
Journal Article
Open access
PDF file
TRTanmoy Roychowdhury
Tanmoy Roychowdhury
DKDerek Klarin
Derek Klarin
MLMichael G. Levin
Michael G. Levin
JSJoshua M. Spin
Joshua M. Spin
YRYae Hyun Rhee
Yae Hyun Rhee
SDScott M. Damrauer
Scott M. Damrauer
Abdominal aortic aneurysm (AAA) is a common disease with substantial heritability. In this study, we performed a genome-wide association meta-analysis from 14 discovery cohorts and uncovered 141 independent associations, including 97 previously unreported loci. A polygenic risk score derived from meta-analysis explained AAA risk beyond clinical risk factors. Genes at AAA risk loci indicate involvement of lipid metabolism, vascular development and remodeling, extracellular matrix dysregulation and inflammation as key mechanisms in AAA pathogenesis. These genes also indicate overlap between the development of AAA and other monogenic aortopathies, particularly via transforming growth factor β signaling. Motivated by the strong evidence for the role of lipid metabolism in AAA, we used Mendelian randomization to establish the central role of nonhigh-density lipoprotein cholesterol in AAA and identified the opportunity for repurposing of proprotein convertase, subtilisin/kexin-type 9 (PCSK9) inhibitors. This was supported by a study demonstrating that PCSK9 loss of function prevented the development of AAA in a preclinical mouse model.

6 November 2023 in Nature Genetics
Verified
Journal Article
Open access
PDF file
SSSimon N. Stacey
Simon N. Stacey
FZFlorian Zink
Florian Zink
GHGisli H. Halldorsson
Gisli H. Halldorsson
LSLilja Stefansdottir
Lilja Stefansdottir
SGSigurjon A. Gudjonsson
Sigurjon A. Gudjonsson
KSKari Stefansson
Kari Stefansson
Clonal hematopoiesis (CH) arises when a substantial proportion of mature blood cells is derived from a single hematopoietic stem cell lineage. Using whole-genome sequencing of 45,510 Icelandic and 130,709 UK Biobank participants combined with a mutational barcode method, we identified 16,306 people with CH. Prevalence approaches 50% in elderly participants. Smoking demonstrates a dosage-dependent impact on risk of CH. CH associates with several smoking-related diseases. Contrary to published claims, we find no evidence that CH is associated with cardiovascular disease. We provide evidence that CH is driven by genes that are commonly mutated in myeloid neoplasia and implicate several new driver genes. The presence and nature of a driver mutation alters the risk profile for hematological disorders. Nevertheless, most CH cases have no known driver mutations. A CH genome-wide association study identified 25 loci, including 19 not implicated previously in CH. Splicing, protein and expression quantitative trait loci were identified for CD164 and TCL1A.

2 February 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
GBGyda Bjornsdottir
Gyda Bjornsdottir
LSLilja Stefansdottir
Lilja Stefansdottir
GTGudmar Thorleifsson
Gudmar Thorleifsson
PSPatrick Sulem
Patrick Sulem
KNKristjan Norland
Kristjan Norland
GCGO Consortium
GO Consortium
Back pain is a common and debilitating disorder with largely unknown underlying biology. Here we report a genome-wide association study of back pain using diagnoses assigned in clinical practice; dorsalgia (119,100 cases, 909,847 controls) and intervertebral disc disorder (IDD) (58,854 cases, 922,958 controls). We identify 41 variants at 33 loci. The most significant association (ORIDD = 0.92, P = 1.6 × 10−39; ORdorsalgia = 0.92, P = 7.2 × 10−15) is with a 3’UTR variant (rs1871452-T) in CHST3, encoding a sulfotransferase enzyme expressed in intervertebral discs. The largest effects on IDD are conferred by rare (MAF = 0.07 − 0.32%) loss-of-function (LoF) variants in SLC13A1, encoding a sodium-sulfate co-transporter (LoF burden OR = 1.44, P = 3.1 × 10−11); variants that also associate with reduced serum sulfate. Genes implicated by this study are involved in cartilage and bone biology, as well as neurological and inflammatory processes.

26 October 2023 in Nature Genetics
Verified
Journal Article
Open access
PDF file
GBGyda Bjornsdottir
Gyda Bjornsdottir
MCMona Ameri Chalmer
Mona Ameri Chalmer
LSLilja Stefansdottir
Lilja Stefansdottir
ASAstros Th. Skuladottir
Astros Th. Skuladottir
GEGudmundur Einarsson
Gudmundur Einarsson
KSKari Stefansson
Kari Stefansson
Migraine is a complex neurovascular disease with a range of severity and symptoms, yet mostly studied as one phenotype in genome-wide association studies (GWAS). Here we combine large GWAS datasets from six European populations to study the main migraine subtypes, migraine with aura (MA) and migraine without aura (MO). We identified four new MA-associated variants (in PRRT2, PALMD, ABO and LRRK2) and classified 13 MO-associated variants. Rare variants with large effects highlight three genes. A rare frameshift variant in brain-expressed PRRT2 confers large risk of MA and epilepsy, but not MO. A burden test of rare loss-of-function variants in SCN11A, encoding a neuron-expressed sodium channel with a key role in pain sensation, shows strong protection against migraine. Finally, a rare variant with cis-regulatory effects on KCNK5 confers large protection against migraine and brain aneurysms. Our findings offer new insights with therapeutic potential into the complex biology of migraine and its subtypes.

28 May 2019
Verified
Book Chapter
Closed access
PDF file
RPRasmus R. Paulsen
Rasmus R. Paulsen
KJKristine Aavild Juhl
Kristine Aavild Juhl
THThilde Marie Haspang
Thilde Marie Haspang
THThomas Hansen
Thomas Hansen
MGMelanie Ganz
Melanie Ganz
GEGudmundur Einarsson
Gudmundur Einarsson

24 March 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
ASAstros Th. Skuladottir
Astros Th. Skuladottir
GBGyda Bjornsdottir
Gyda Bjornsdottir
EFEgil Ferkingstad
Egil Ferkingstad
GEGudmundur Einarsson
Gudmundur Einarsson
LSLilja Stefansdottir
Lilja Stefansdottir
DCDBDS Genetic Consortium
DBDS Genetic Consortium
Carpal tunnel syndrome (CTS) is the most common entrapment neuropathy and has a largely unknown underlying biology. In a genome-wide association study of CTS (48,843 cases and 1,190,837 controls), we found 53 sequence variants at 50 loci associated with the syndrome. The most significant association is with a missense variant (p.Glu366Lys) in SERPINA1 that protects against CTS (P = 2.9 × 10−24, OR = 0.76). Through various functional analyses, we conclude that at least 22 genes mediate CTS risk and highlight the role of 19 CTS variants in the biology of the extracellular matrix. We show that the genetic component to the risk is higher in bilateral/recurrent/persistent cases than nonrecurrent/nonpersistent cases. Anthropometric traits including height and BMI are genetically correlated with CTS, in addition to early hormonal-replacement therapy, osteoarthritis, and restlessness. Our findings suggest that the components of the extracellular matrix play a key role in the pathogenesis of CTS.